GlassScriptPhysician profile
Farhad Farokhi
NPI 1639153216
$33,953.66
in general payments reported to CMS, 2019-2025
20 companies · $166 in 2025
The $166 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $4,840 · 2021: $2,997 · 2022: $605 · 2023: $502 · 2024: $2,924 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,921 · Food and Beverage: $1,671.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,921.49 |
| Food and Beverage | $1,670.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18,027.42 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $11,138.31 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $1,936.38 | 2020-2024 | Watchman Access System |
| Abbott Laboratories | $1,295.14 | 2019-2025 | Ensite Precision, Ensite, Cardiomems |
| Medtronic, INC. | $702.54 | 2021-2024 | Micra, Selectsecure, Percepta Quad Crt-P Mri Surescan |
| Medtronic Vascular, INC. | $146.57 | 2019 | |
| Impulse Dynamics (USA) INC. | $130.39 | 2022-2023 | Optimizer |
| Novartis Pharmaceuticals Corporation | $95.17 | 2023-2024 | |
| Becton, Dickinson and Company | $85.73 | 2025 | Hemosphere |
| Edwards Lifesciences Corporation | $75.65 | 2024-2025 | Hemosphere, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Atricure, INC. | $72.98 | 2019 | |
| Siemens Medical Solutions USA, INC. | $69.23 | 2024 | Acuson Sc2000 Diagnostic Ultrasound System |
| Cardiva Medical, INC. | $57.73 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.92 | 2023 | Jardiance |
| Merck Sharp & Dohme LLC | $23.70 | 2024 | Bridion |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals, LTD. | $20.22 | 2021 | |
| Altathera Pharmaceuticals LLC | $14.84 | 2025 | Sotalol Hydrochloride |
| Biosense Webster, INC. | $13.10 | 2024 | Carto 3 |
| Philips North America LLC | $12.64 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Farhad Farokhi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.